DRUG vs. NXL
DRUG (Bright Minds Biosciences Inc) and NXL (Nexalin Technology Inc.) are both stocks. Both are in the Healthcare sector — DRUG in Biotechnology, NXL in Medical Devices. Over the past 3 years, DRUG returned 208.66%/yr vs -18.23%/yr for NXL. At a 0.06 correlation, their price movements are largely independent.
Performance
DRUG vs. NXL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DRUG achieves a -0.26% return, which is significantly higher than NXL's -17.44% return.
DRUG
- 1D
- -0.46%
- 1M
- 27.71%
- 6M
- -10.27%
- YTD
- -0.26%
- 1Y
- 213.74%
- 3Y*
- 208.66%
- 5Y*
- 27.08%
- 10Y*
- —
NXL
- 1D
- 1.92%
- 1M
- 6.89%
- 6M
- -35.33%
- YTD
- -17.44%
- 1Y
- -53.70%
- 3Y*
- -18.23%
- 5Y*
- —
- 10Y*
- —
DRUG vs. NXL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
DRUG Bright Minds Biosciences Inc | -0.26% | 116.66% | 2,418.88% | -61.35% | -42.19% |
NXL Nexalin Technology Inc. | -17.44% | -79.78% | 581.82% | -45.95% | -72.26% |
Correlation
The correlation between DRUG and NXL is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2022 | 0.06 |
Fundamentals
DRUG:
$604.16M
NXL:
$9.48M
DRUG:
-CA$3.37
NXL:
-$0.44
DRUG:
3.43
NXL:
3.16
DRUG:
CA$0.00
NXL:
$275.58K
DRUG:
-CA$20.13K
NXL:
-$950.31K
DRUG:
-CA$31.36M
NXL:
-$8.37M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRUG vs. NXL — Risk / Return Rank
DRUG
NXL
DRUG vs. NXL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and Nexalin Technology Inc. (NXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DRUG | NXL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.12 | ||
| Sortino ratioReturn per unit of downside risk | +3.12 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.02 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 5.25 | -0.65 | +5.91 |
| Martin ratioReturn relative to average drawdown | 12.68 | -0.91 | +13.58 |
Loading charts...
Drawdowns
DRUG vs. NXL - Drawdown Comparison
The maximum DRUG drawdown since its inception was -97.68%, which is greater than NXL's maximum drawdown of -92.64%. Use the drawdown chart below to compare losses from any high point for DRUG and NXL.
Loading charts...
Drawdown Indicators
| DRUG | NXL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.68% | -92.64% | -5.04% |
Max Drawdown (1Y)Largest decline over 1 year | -38.35% | -82.74% | +44.39% |
Max Drawdown (3Y)Largest decline over 3 years | -76.98% | -92.64% | +15.66% |
Max Drawdown (5Y)Largest decline over 5 years | -97.68% | — | — |
Current DrawdownCurrent decline from peak | -18.90% | -89.43% | +70.53% |
Average DrawdownAverage peak-to-trough decline | -58.46% | -66.72% | +8.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.87% | 59.41% | -43.54% |
Volatility
DRUG vs. NXL - Volatility Comparison
The current volatility for Bright Minds Biosciences Inc (DRUG) is 20.83%, while Nexalin Technology Inc. (NXL) has a volatility of 29.06%. This indicates that DRUG experiences smaller price fluctuations and is considered to be less risky than NXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRUG | NXL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.83% | 29.06% | -8.23% |
Volatility (6M)Calculated over the trailing 6-month period | 41.99% | 72.25% | -30.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.14% | 147.11% | -73.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 662.76% | 164.89% | +497.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 643.50% | 164.89% | +478.61% |
Dividends
DRUG vs. NXL - Dividend Comparison
Neither DRUG nor NXL has paid dividends to shareholders.
Financials
DRUG vs. NXL - Financials Comparison
This section allows you to compare key financial metrics between Bright Minds Biosciences Inc and Nexalin Technology Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DRUG and NXL have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NXL has higher volatility (29.06%) compared to DRUG (20.83%). In terms of maximum drawdown, DRUG dropped -97.68% vs NXL's -92.64%.
DRUG currently has the higher Sharpe Ratio (2.76 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DRUG and NXL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer